Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics

Quest Diagnostics (DGX) recently announced a collaboration with Ultima Genomics, the developer of the revolutionary new ultra-high throughput sequencing architecture. Through the collaboration, the companies aim to improve patient access, affordability and outcomes by expanding the use of highly accurate, cost-efficient and high-volume whole genome sequencing in fast-growth areas, such as solid-tumor minimal residual disease (MRD) testing.The latest development will significantly fortify Quest Diagnostics’ ...